Jacques Hamon
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Receptor Mechanisms and Signaling, Pharmacogenetics and Drug Metabolism, Neuroscience and Neuropharmacology Research, DNA Repair Mechanisms
Most-Cited Works
- → Large-scale prediction and testing of drug activity on side-effect targets(2012)886 cited
- → Reducing safety-related drug attrition: the use of in vitro pharmacological profiling(2012)736 cited
- → Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation(2013)463 cited
- → Keynote review: In vitro safety pharmacology profiling: an essential tool for successful drug development(2005)408 cited
- → Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off‐Target Effects from Chemical Structure(2007)323 cited
- → Alkylamides from Echinacea Are a New Class of Cannabinomimetics(2006)256 cited
- → Modeling Promiscuity Based on in vitro Safety Pharmacology Profiling Data(2007)177 cited
- → Mapping Adverse Drug Reactions in Chemical Space(2009)157 cited
- → Gaining Insight into Off-Target Mediated Effects of Drug Candidates with a Comprehensive Systems Chemical Biology Analysis(2009)154 cited
- → Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancers(2024)98 cited